AIMLF logo

AI/ML Innovations Inc. (AIMLF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören AI/ML Innovations Inc. (AIMLF), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 15 Mar 2026
46/100 AI Puanı

AI/ML Innovations Inc. (AIMLF) Sağlık ve Boru Hattı Genel Bakışı

CEOJohn Paul Duffy
MerkezVictoria, CA
Halka Arz Yılı1996
SektörHealthcare

AI/ML Innovations Inc. develops AI and machine learning-driven digital healthcare solutions, including a personal health monitoring system and wearable tech. Targeting caregivers, patients, and healthcare professionals, the company aims to improve recovery outcomes. It operates in the competitive healthcare information services sector, facing established and emerging players.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 15 Mar 2026

Yatırım Tezi

AI/ML Innovations Inc. operates in the high-growth digital healthcare market, driven by increasing adoption of AI and ML technologies. However, the company's negative profit margin of -3910.2% and gross margin of -249.6% raise concerns about its financial sustainability. A potential catalyst is the further development and commercialization of its patent-pending health monitoring system. Key risks include the need for significant capital to scale operations and competition from larger, more established players in the healthcare information services sector. Investors should closely monitor the company's ability to improve its financial performance and secure strategic partnerships.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • AI/ML Innovations Inc. operates in the digital healthcare sector, focusing on AI and machine learning applications.
  • The company's personal health monitoring system is patent-pending, potentially offering a competitive advantage.
  • The company's profit margin is -3910.2%, indicating significant losses.
  • The company's gross margin is -249.6%, suggesting challenges in cost management.
  • The company's market capitalization is $0.00B, reflecting its small size and early stage of development.

Rakipler & Benzerleri

Güçlü Yönler

  • Patent-pending personal health monitoring system.
  • Focus on AI and machine learning in healthcare.
  • Integrated digital health solutions.
  • Potential for data-driven insights.

Zayıflıklar

  • Negative profit margin and gross margin.
  • Limited market presence and brand recognition.
  • Dependence on external funding.
  • Small market capitalization.

Katalizörler

  • Upcoming: Potential partnerships with healthcare providers to expand market reach.
  • Ongoing: Development and commercialization of the patent-pending health monitoring system.
  • Ongoing: Expansion of the company's digital health software offerings.
  • Upcoming: Securing additional funding to support growth initiatives.
  • Ongoing: Increasing adoption of AI and ML technologies in the healthcare sector.

Riskler

  • Ongoing: Negative profit margin and gross margin raise concerns about financial sustainability.
  • Potential: Intense competition from larger, more established players in the healthcare information services sector.
  • Potential: Regulatory hurdles and compliance requirements could delay product development and commercialization.
  • Potential: Dependence on external funding to support operations and growth.
  • Ongoing: Low liquidity and price volatility due to OTC listing.

Büyüme Fırsatları

  • Expansion of the personal health monitoring system: The company's patent-pending personal health monitoring system presents a significant growth opportunity. By expanding the system's capabilities and targeting specific patient populations, AI/ML Innovations can increase its market share. The market for remote patient monitoring is projected to reach $175.2 billion by 2027, offering a substantial addressable market.
  • Strategic partnerships with healthcare providers: Collaborating with hospitals, clinics, and other healthcare providers can accelerate the adoption of AI/ML Innovations' solutions. These partnerships can provide access to a wider patient base and facilitate the integration of the company's technology into existing healthcare workflows. This is an ongoing opportunity as healthcare providers increasingly seek digital solutions.
  • Development of new wearable technologies: The company can leverage its expertise in AI and ML to develop new wearable technologies that address specific healthcare needs. These technologies can provide real-time data and insights, enabling more proactive and personalized care. The global wearable medical devices market is expected to reach $29.6 billion by 2029, presenting a significant growth avenue.
  • Geographic expansion into new markets: AI/ML Innovations can expand its reach by targeting new geographic markets. This can involve adapting its solutions to meet the specific needs of different regions and establishing partnerships with local distributors and healthcare providers. This is an ongoing opportunity as the company seeks to broaden its global footprint.
  • Data analytics and insights: Leveraging the data collected through its health monitoring system and wearable technologies, AI/ML Innovations can provide valuable insights to healthcare providers and patients. This can involve developing predictive models, identifying trends, and personalizing treatment plans. The market for healthcare analytics is projected to reach $75 billion by 2026, offering a significant growth opportunity.

Fırsatlar

  • Expansion into new geographic markets.
  • Strategic partnerships with healthcare providers.
  • Development of new wearable technologies.
  • Increasing adoption of digital health solutions.

Tehditler

  • Intense competition from larger, more established players.
  • Regulatory hurdles and compliance requirements.
  • Rapid technological advancements.
  • Economic downturns and reduced healthcare spending.

Rekabet Avantajları

  • Patent-Pending Technology: The patent-pending personal health monitoring system provides a degree of exclusivity.
  • Data-Driven Insights: The ability to collect and analyze data to provide valuable insights.
  • Integrated Solutions: Offering a comprehensive suite of digital health solutions.
  • Focus on AI/ML: Specialization in artificial intelligence and machine learning within the healthcare sector.

AIMLF Hakkında

AI/ML Innovations Inc., formerly AIML Resources Inc., was incorporated in 2009 and rebranded in November 2020 to reflect its focus on artificial intelligence and machine learning within the healthcare sector. Headquartered in Victoria, Canada, the company develops and markets digital health solutions, including a patent-pending personal health monitoring and management system. This system is designed for use by caregivers, patients, and healthcare professionals, providing tools to access and utilize data to improve recovery outcomes and promote healthy living. AI/ML Innovations also develops digital health software and wearable technologies. The company's core focus is leveraging AI and ML to create innovative solutions that address the evolving needs of the healthcare industry, with an emphasis on personalized health management and improved patient outcomes. The company aims to establish itself as a key player in the digital healthcare market by offering integrated and data-driven solutions.

Ne Yaparlar

  • Develop a patent-pending personal health monitoring and management system.
  • Create digital health software solutions.
  • Design and market wearable technologies for healthcare.
  • Provide data-driven insights for caregivers and healthcare professionals.
  • Offer solutions for enhanced recovery outcomes.
  • Focus on promoting healthy living through technology.

İş Modeli

  • Software as a Service (SaaS): Recurring revenue from subscriptions to the health monitoring system.
  • Wearable Technology Sales: Revenue from the sale of wearable devices.
  • Data Analytics Services: Revenue from providing data analytics and insights to healthcare providers.
  • Partnerships: Revenue from strategic partnerships with healthcare providers and distributors.

Sektör Bağlamı

AI/ML Innovations Inc. operates within the rapidly expanding digital healthcare market, which is experiencing significant growth due to the increasing adoption of AI and machine learning technologies. The market is characterized by intense competition, with established players and emerging startups vying for market share. Key trends include the rise of personalized medicine, remote patient monitoring, and data-driven healthcare solutions. Competitors include companies like Ayr Wellness Inc. (AYRWF), Ayr Strategies Inc. (AYURF), and CM Life Sciences Inc. (CMHSF). AI/ML Innovations aims to carve out a niche by offering integrated and user-friendly digital health solutions.

Kilit Müşteriler

  • Caregivers: Providing tools to monitor and manage the health of their patients or loved ones.
  • Patients: Empowering individuals to take control of their health and recovery.
  • Healthcare Professionals: Offering data-driven insights to improve patient care and outcomes.
AI Güveni: 71% Güncellendi: 15 Mar 2026

Finansallar

Grafik & Bilgi

AI/ML Innovations Inc. (AIMLF) hisse senedi fiyatı: Price data unavailable

Son Haberler

AIMLF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

AIMLF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

AIMLF için Wall Street fiyat hedefi analizi.

MoonshotScore

46/100

Bu puan ne anlama geliyor?

MoonshotScore, AIMLF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: John Paul Duffy

CEO

John Paul Duffy is the CEO of AI/ML Innovations Inc. His background includes experience in technology and business development, with a focus on identifying and capitalizing on emerging market trends. He has a track record of leading companies through periods of growth and innovation. Duffy's expertise lies in strategic planning, market analysis, and building strong teams to execute on business objectives. He is committed to driving AI/ML Innovations Inc.'s mission of transforming healthcare through AI and machine learning.

Sicil: Under John Paul Duffy's leadership, AI/ML Innovations Inc. has focused on developing its patent-pending personal health monitoring system and expanding its digital health software offerings. He has overseen the company's rebranding to reflect its focus on AI and ML. Duffy has also been instrumental in forging strategic partnerships and securing funding to support the company's growth initiatives. Key milestones include the launch of the health monitoring system and the expansion of the company's customer base.

AIMLF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that AI/ML Innovations Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for stocks on the OTC Other tier, like AIMLF, is typically very low. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. The low trading volume can also lead to significant price volatility, increasing the risk of substantial losses. Investors should exercise caution and be prepared for potential difficulties in trading AIMLF shares.
OTC Risk Faktörleri:
  • Limited Financial Disclosure: The lack of comprehensive financial reporting increases the risk of investing in AIMLF.
  • Low Liquidity: The low trading volume can make it difficult to buy or sell shares.
  • Price Volatility: The stock price may be subject to significant fluctuations.
  • Potential for Fraud: The OTC Other tier is more susceptible to fraudulent activities.
  • Regulatory Scrutiny: AIMLF may face increased regulatory scrutiny due to its OTC listing.
Durum Tespiti Kontrol Listesi:
  • Verify the company's management team and their track record.
  • Review any available financial statements and assess the company's financial health.
  • Research the company's business model and competitive landscape.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory filings or legal issues.
  • Assess the company's long-term growth potential.
Meşruiyet Sinyalleri:
  • Focus on AI and machine learning in healthcare.
  • Development of a patent-pending personal health monitoring system.
  • Presence of a CEO with relevant experience.
  • Company's stated mission to transform healthcare through technology.
  • Headquartered in Canada, a country with strong corporate governance standards.

AI/ML Innovations Inc. Hissesi: Cevaplanan Temel Sorular

AIMLF için değerlendirilmesi gereken temel faktörler nelerdir?

AI/ML Innovations Inc. (AIMLF) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Temel güçlü yan: Patent-pending personal health monitoring system.. İzlenmesi gereken birincil risk: Ongoing: Negative profit margin and gross margin raise concerns about financial sustainability.. Bu bir finansal tavsiye değildir.

AIMLF MoonshotScore'u nedir?

AIMLF şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

AIMLF verileri ne sıklıkla güncellenir?

AIMLF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler AIMLF hakkında ne diyor?

AIMLF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

AIMLF'a yatırım yapmanın riskleri nelerdir?

AIMLF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Negative profit margin and gross margin raise concerns about financial sustainability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

AIMLF'ın P/E oranı nedir?

AIMLF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için AIMLF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

AIMLF aşırı değerli mi, yoksa düşük değerli mi?

AI/ML Innovations Inc. (AIMLF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

AIMLF'ın temettü verimi nedir?

AI/ML Innovations Inc. (AIMLF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is limited and may not be fully up-to-date.
  • OTC market stocks carry higher risks than exchange-listed stocks.
  • AI analysis is pending and not yet factored into this report.
Veri Kaynakları

Popüler Hisseler